tiprankstipranks
Newmed Energy Limited Partnership (IL:NWMD)
TASE:NWMD
Want to see IL:NWMD full AI Analyst Report?

Newmed Energ Pu (NWMD) Price & Analysis

7 Followers

NWMD Stock Chart & Stats

1620.00
-11.00(-0.69%)
At close: 4:00 PM EDT
1620.00
-11.00(-0.69%)

Bulls Say, Bears Say

Bulls Say
Production And Revenue ExpansionHigher production across Israel, Egypt, and Jordan, combined with stronger realized prices, demonstrates improving asset utilization and regional demand. Sustained volume growth can support recurring revenue and operating leverage as infrastructure expands.
Infrastructure Capacity GrowthNew pipeline and transmission capacity remove infrastructure constraints and broaden export capability. This improves the ability to monetize Leviathan production over time, although the timing and allocation of benefits vary across partners.
Visible Development PipelineProgress on Leviathan expansion and Aphrodite provides a multi-year path for reserve development and production growth. Long-lead procurement, FEED work, and planned drilling reduce uncertainty around future capacity additions.
Bears Say
Sharp Free Cash Flow DeteriorationWeak cash conversion means reported profitability is not translating efficiently into discretionary cash. Higher working capital, taxes, interest, or sustaining capital needs could constrain debt reduction, distributions, and funding for major projects.
Debt Refinancing And Flexibility RiskAlthough leverage has improved historically, substantial net debt and a near-term maturity create refinancing exposure. Dependence on available facilities and bond buybacks could limit financial flexibility if earnings or cash generation weaken.
Margin And Commodity-Cycle PressureThe decline in margins and uneven multi-year revenue performance highlight exposure to gas prices, contract realizations, and operating costs. This cyclicality can make earnings less predictable and reduce the durability of returns during weaker market phases.

Newmed Energ Pu News

NWMD FAQ

What was Newmed Energy Limited Partnership’s price range in the past 12 months?
Newmed Energy Limited Partnership lowest stock price was 1458.54 and its highest was 2248.17 in the past 12 months.
    What is Newmed Energy Limited Partnership’s market cap?
    Newmed Energy Limited Partnership’s market cap is ₪19.43B.
      When is Newmed Energy Limited Partnership’s upcoming earnings report date?
      Newmed Energy Limited Partnership’s upcoming earnings report date is Nov 12, 2026 which is in 84 days.
        How were Newmed Energy Limited Partnership’s earnings last quarter?
        Newmed Energy Limited Partnership released its earnings results on Aug 06, 2026. The company reported 27.9 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
          Is Newmed Energy Limited Partnership overvalued?
          According to Wall Street analysts Newmed Energy Limited Partnership’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Newmed Energy Limited Partnership pay dividends?
            Newmed Energy Limited Partnership pays a Quarterly dividend of 15.219 which represents an annual dividend yield of 3.76%. See more information on Newmed Energy Limited Partnership dividends here
              What is Newmed Energy Limited Partnership’s EPS estimate?
              Newmed Energy Limited Partnership’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Newmed Energy Limited Partnership have?
              Newmed Energy Limited Partnership has 1,173,814,700 shares outstanding.
                What happened to Newmed Energy Limited Partnership’s price movement after its last earnings report?
                Newmed Energy Limited Partnership reported an EPS of 27.9 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.926%.
                  Which hedge fund is a major shareholder of Newmed Energy Limited Partnership?
                  Currently, no hedge funds are holding shares in IL:NWMD
                  What is the TipRanks Smart Score and how is it calculated?
                  Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                    Company Description

                    Newmed Energy Limited Partnership

                    NewMed Energy - Limited Partnership is an energy firm engaged in the exploration, development, production, and commercialization of petroleum, natural gas, and condensate, primarily operating in Israel and Cyprus. The company holds significant interests in several key offshore endeavors, including Israel's Leviathan project (500 km², situated west of Haifa's coast), the Yam Tethys project (500 km², west of Ashkelon's coast), and the Tanin and Karish leases (500 km², west of Nahariya's coast). Its portfolio also extends to Block 12 in Cyprus (approximately 386 km²) and the substantial Boujdour Atlantique exploration license (around 33,812 km²) located in the southern Moroccan exclusive economic zone. NewMed Energy supplies natural gas to various clients, such as independent power producers, marketing companies, and industrial consumers, and exports natural gas to Jordan and Egypt. NewMed Energy Management Ltd. functions as the company's general partner. Originally incorporated in Herzliya, Israel, in 1993, the company was formerly known as Delek Drilling - Limited Partnership before adopting its current name in February 2022. It operates as a subsidiary of Delek Energy Systems Ltd.

                    Newmed Energ Pu (NWMD) Earnings & Revenues

                    NWMD Company Deck

                    NWMD Earnings Call

                    Q1 2026
                    0:00 / 0:00
                    Earnings Call Sentiment|Positive
                    The call presented multiple strong operational and financial improvements: production increased ~35%, revenues rose ~53% and net income ~44%, supported by higher gas prices and completed midstream works. Material infrastructure milestones (third pipeline, Ashdod–Ashkelon looping) and progress on major growth projects (Leviathan expansion on schedule, Aphrodite progressing toward FID) provide clear upside. Offsetting considerations include rising operating costs (+$21M), higher finance expenses (+$26M), net debt of ~$1.4B with an upcoming bond maturity in 2027, and some benefits that are timing‑lagged or accrue to partners rather than immediately to NewMed. Overall, positive momentum and meaningful value catalysts outweigh the noted financial and timing challenges.View all IL:NWMD earnings summaries
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Delek Group
                    Isramco Pu
                    Tomer Energy
                    Tamar Pet
                    Navitas Ptro Pu
                    Popular Stocks